Literature DB >> 3922198

The brain octopamine and phenylethanolamine content in rats in thioacetamide-induced hepatogenic encephalopathy.

W Hilgier, A Zitting, J Albrecht.   

Abstract

The brain octopamine (OA) and phenylethanolamine (PhEA) content was determined in rats subjected to repeated intraperitoneal administrations of thioacetamide (TAA) known to produce different stages of hepatogenic encephalopathy (HE). A more than 2.5-fold increase of OA and a 2-fold increase of PhEA was observed after prolonged (3 times) administration of TAA, coinciding with impaired ammonia detoxication in brain and with the onset of pathophysiological changes typical for HE. Only insignificant changes in the content of the amines were observed in the early stages of the experiment as well as in the recovery period. The results are consistent with the "false neurotransmitter" hypothesis of Fischer and Baldessarini, assuming the participation of OA and PhEA in the pathogenesis of HE.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922198     DOI: 10.1111/j.1600-0404.1985.tb03188.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.

Authors:  J W Thomas; C Banner; J Whitman; K D Mullen; E Freese
Journal:  Metab Brain Dis       Date:  1988-06       Impact factor: 3.584

2.  Effect of acute thioacetamide administration on rat brain phospholipid metabolism.

Authors:  J Osada; H Aylagas; M J Mirõ-Obradors; C Arce; E Palacios-Alaiz; M Cascales
Journal:  Neurochem Res       Date:  1990-09       Impact factor: 3.996

3.  Brain edema in acute liver failure: inhibition by L-histidine.

Authors:  Kakulavarapu V Rama Rao; Pichili V B Reddy; Xiaoying Tong; Michael D Norenberg
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

Review 4.  Alterations of blood brain barrier function in hyperammonemia: an overview.

Authors:  Marta Skowrońska; Jan Albrecht
Journal:  Neurotox Res       Date:  2011-08-27       Impact factor: 3.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.